glp-1 obesity drug market forecast 2030 Agonists Report 2025-2033, By Product, Molecule, and Geo Obesity Drugs Market Research Report
Description
You need results quickly
Corrigendum: Glp-1ras caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis
Patients may know tirzepatide by brand names such as Mounjaro and Zepbound
GLP-1 receptor agonist as treatment for cancer as well as diabetes: Beyond blood glucose control
Mitri J, Hamdy O
